Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of three anesthetic combinations for shoulder reduction
IRCT2017032323559N10Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of succinylcholine, thiopental, propofol, fentanyl and midazolam in Glenohumeral dislocation (GHD) (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Success rate of shoulder reduction and Complication rate during shoulder reduction. Status: unknown.
02
Drugs
succinylcholinethiopentalpropofolfentanylmidazolam
03
Conditions
Glenohumeral dislocation (GHD)
Beyond the preview
Go deeper on IRCT2017032323559N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017032323559N10.